<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001390947</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0002013745</issuerCik>
      <issuerName>Calumet, Inc. /DE</issuerName>
      <secFileNumber>001-42172</secFileNumber>
      <issuerAddress>
        <com:street1>1060 N CAPITOL AVE</com:street1>
        <com:street2>SUITE 6-401</com:street2>
        <com:city>INDIANAPOLIS</com:city>
        <com:stateOrCountry>IN</com:stateOrCountry>
        <com:zipCode>46204</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(317) 328-5660</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Straumins Jennifer</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill</name>
        <address>
          <com:street1>219 Main St N</com:street1>
          <com:city>Stillwater</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55082</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>200000</noOfUnitsSold>
      <aggregateMarketValue>4064031.70</aggregateMarketValue>
      <noOfUnitsOutstanding>85904105</noOfUnitsOutstanding>
      <approxSaleDate>11/12/2024</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <acquiredDate>07/10/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Common Stock, par value $0.01 per share, acquired pursuant to Calumet, Inc. Conversion Agreement</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Calumet, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>825000</amountOfSecuritiesAcquired>
      <paymentDate>07/10/2024</paymentDate>
      <natureOfPayment>Securites in kind</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. the Partnership, pursuant to which the Partnership converted from a master limited partnership to a corporation the Conversion, Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner the General Partner of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. the GP Merger. Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share the Common Stock, and 2,000,000 warrants to purchase Common Stock the Warrants. In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share Common Stock, and 300,000 warrants to purchase Common Stock.</remarks>
    <noticeSignature>
      <noticeDate>11/14/2024</noticeDate>
      <signature>Jennifer Straumins</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
